Life Science Company and Industry News Briefs

Cincinnati Researchers Receive $1.6M to Study Rare Lung Disease

Posted by Laura Braden on Wed, May 13, 2015

Pulmonary alveolar microlithiasis (PAM) is a rare lung disease that has only been recorded about 700 times in medical literature. In order for someone to get PAM, both parents must have the genetic mutation that causes it. Although rare, this disease can result in a much shorter life expectancy or death. With the help of a new grant worth $1.6 million over the next four years from the National Heart, Lung, and Blood Institute of the NIH, researchers at the University of Cincinnati will further study this rare disease. (Image courtesy of Wikimedia Commons)

Read More

Tags: Midwest, University of Cincinnati, 2015, BioResearch Product Faire Event, Cincinnati, OH, UCinci, NIH funding, Lung Disease, pulmonary alveolar microlithiasis

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to Science Market Update